Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2′-pyridylisatogen tosylate and related compounds

2,2′-Pyridylisatogen tosylate (PIT) is both an allosteric modulator of P2Y receptors, and an immine oxide, acting as a spin trap for free radicals. PIT (10 mg kg −1, i.p.) was found to be a powerful neuroprotective agent in protecting against the lesions induced by 15 μg S-bromo-willardiine injected...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 2002-05, Vol.444 (1), p.53-60
Hauptverfasser: Menton, Kevin, Spedding, Michael, Gressens, Pierre, Villa, Pascal, Williamson, Toni, Markham, Anthony
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 60
container_issue 1
container_start_page 53
container_title European journal of pharmacology
container_volume 444
creator Menton, Kevin
Spedding, Michael
Gressens, Pierre
Villa, Pascal
Williamson, Toni
Markham, Anthony
description 2,2′-Pyridylisatogen tosylate (PIT) is both an allosteric modulator of P2Y receptors, and an immine oxide, acting as a spin trap for free radicals. PIT (10 mg kg −1, i.p.) was found to be a powerful neuroprotective agent in protecting against the lesions induced by 15 μg S-bromo-willardiine injected into the cortex or white matter of 5-day-old mice pups. As the multiple effects of PIT may induce both beneficial and deleterious effects, a reanalysis of the structure–activity relationship was undertaken. PIT (50 μM) and 2,3′-pyridylisatogen were potent antagonists of responses to ATP in the taenia preparation of the guinea-pig caecum, but 2,3′-nitrophenylisatogen was not. The reactive immine oxide group could be substituted by a keto moiety ( N-(2′-pyridyl)phthalide) while maintaining antagonism of responses to ATP, equivalent to PIT. Thus, antagonism of P2Y receptors was not restricted to the isatogen nucleus. Other spin traps did not antagonise P2Y receptors, although dimethyl-pyrroline- N-oxide (DMPO) increased the sensitivity of responses to ATP. Both N-(2′-pyridyl)phthalide and 2,3′-nitrophenylisatogen was less neuroprotective than PIT (10 mg kg −1, i.p.) in protecting against the S-bromo-willardiine-induced lesions in mice, implying that both antagonism of P2Y receptors and the immine oxide moiety may be important for the neuroprotective effects of PIT. However, the usefulness of the neuroprotection was limited because, in motoneurones obtained from rat embryos, PIT (10–100 μM) exacerbated cell death.
doi_str_mv 10.1016/S0014-2999(02)01583-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72027431</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299902015832</els_id><sourcerecordid>72027431</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-e1d9b91eb1e90acb411b89e7dd157f3c87ce9372d711986d66fbee3de0a1edc33</originalsourceid><addsrcrecordid>eNqFkc2KFDEUhYMoTjv6CEo2ioKluUlXpbISGfyDAcWfhauQSm61kapKmaQGeufW1_GRfBJT3Y2zdHUv4Ts3h3MIuQ_sGTBonn9iDLYVV0o9ZvwJg7oVFb9BNtBKVTEJ_CbZ_EPOyJ2UvjPGasXr2-QMOKii4Bvy62MYkIaeptlPNEczl7mjZnL0A_9KI1qcc4jlIZtdmHwa6cp9QzrhEsMcQ0ab_RVS7PuypfUWf8r__Pxdzfvo3X7wyeSww6IKaT-YjIfrEdfVURvGOSyTS3fJrd4MCe-d5jn58vrV54u31eX7N-8uXl5WVijIFYJTnQLsABUzttsCdK1C6RzUshe2lRaVkNxJANU2rmn6DlE4ZAbQWSHOyaPj3eL9x4Ip69Eni8NgJgxL0pIzLrcCClgfQRtDShF7PUc_mrjXwPTagT50oNeANeP60IHmRffg9MHSjeiuVafQC_DwBJhkzdBHM1mfrrniXohGFu7FkcMSx5XHqJP1OFl0vvSStQv-P1b-Akfzp1s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72027431</pqid></control><display><type>article</type><title>Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2′-pyridylisatogen tosylate and related compounds</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Menton, Kevin ; Spedding, Michael ; Gressens, Pierre ; Villa, Pascal ; Williamson, Toni ; Markham, Anthony</creator><creatorcontrib>Menton, Kevin ; Spedding, Michael ; Gressens, Pierre ; Villa, Pascal ; Williamson, Toni ; Markham, Anthony</creatorcontrib><description>2,2′-Pyridylisatogen tosylate (PIT) is both an allosteric modulator of P2Y receptors, and an immine oxide, acting as a spin trap for free radicals. PIT (10 mg kg −1, i.p.) was found to be a powerful neuroprotective agent in protecting against the lesions induced by 15 μg S-bromo-willardiine injected into the cortex or white matter of 5-day-old mice pups. As the multiple effects of PIT may induce both beneficial and deleterious effects, a reanalysis of the structure–activity relationship was undertaken. PIT (50 μM) and 2,3′-pyridylisatogen were potent antagonists of responses to ATP in the taenia preparation of the guinea-pig caecum, but 2,3′-nitrophenylisatogen was not. The reactive immine oxide group could be substituted by a keto moiety ( N-(2′-pyridyl)phthalide) while maintaining antagonism of responses to ATP, equivalent to PIT. Thus, antagonism of P2Y receptors was not restricted to the isatogen nucleus. Other spin traps did not antagonise P2Y receptors, although dimethyl-pyrroline- N-oxide (DMPO) increased the sensitivity of responses to ATP. Both N-(2′-pyridyl)phthalide and 2,3′-nitrophenylisatogen was less neuroprotective than PIT (10 mg kg −1, i.p.) in protecting against the S-bromo-willardiine-induced lesions in mice, implying that both antagonism of P2Y receptors and the immine oxide moiety may be important for the neuroprotective effects of PIT. However, the usefulness of the neuroprotection was limited because, in motoneurones obtained from rat embryos, PIT (10–100 μM) exacerbated cell death.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/S0014-2999(02)01583-2</identifier><identifier>PMID: 12191582</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>2,2′-Pyridylisatogen ; AMPA receptor ; Animals ; Animals, Newborn ; ATP antagonist ; Biological and medical sciences ; Dose-Response Relationship, Drug ; Female ; Guinea Pigs ; Immine oxide ; Isatin - analogs &amp; derivatives ; Isatin - pharmacology ; Medical sciences ; Mice ; Motoneuron ; Motor Neurons - drug effects ; Muscle Contraction - drug effects ; Muscle, Smooth - drug effects ; Neuropharmacology ; Neuroprotection ; Neuroprotective agent ; Neuroprotective Agents - pharmacology ; P2Y receptor ; Pharmacology. Drug treatments ; Purinergic P2 Receptor Antagonists ; Spin trap ; Spin Trapping ; Structure-Activity Relationship</subject><ispartof>European journal of pharmacology, 2002-05, Vol.444 (1), p.53-60</ispartof><rights>2002 Elsevier Science B.V.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-e1d9b91eb1e90acb411b89e7dd157f3c87ce9372d711986d66fbee3de0a1edc33</citedby><cites>FETCH-LOGICAL-c391t-e1d9b91eb1e90acb411b89e7dd157f3c87ce9372d711986d66fbee3de0a1edc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0014-2999(02)01583-2$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13723367$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12191582$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Menton, Kevin</creatorcontrib><creatorcontrib>Spedding, Michael</creatorcontrib><creatorcontrib>Gressens, Pierre</creatorcontrib><creatorcontrib>Villa, Pascal</creatorcontrib><creatorcontrib>Williamson, Toni</creatorcontrib><creatorcontrib>Markham, Anthony</creatorcontrib><title>Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2′-pyridylisatogen tosylate and related compounds</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>2,2′-Pyridylisatogen tosylate (PIT) is both an allosteric modulator of P2Y receptors, and an immine oxide, acting as a spin trap for free radicals. PIT (10 mg kg −1, i.p.) was found to be a powerful neuroprotective agent in protecting against the lesions induced by 15 μg S-bromo-willardiine injected into the cortex or white matter of 5-day-old mice pups. As the multiple effects of PIT may induce both beneficial and deleterious effects, a reanalysis of the structure–activity relationship was undertaken. PIT (50 μM) and 2,3′-pyridylisatogen were potent antagonists of responses to ATP in the taenia preparation of the guinea-pig caecum, but 2,3′-nitrophenylisatogen was not. The reactive immine oxide group could be substituted by a keto moiety ( N-(2′-pyridyl)phthalide) while maintaining antagonism of responses to ATP, equivalent to PIT. Thus, antagonism of P2Y receptors was not restricted to the isatogen nucleus. Other spin traps did not antagonise P2Y receptors, although dimethyl-pyrroline- N-oxide (DMPO) increased the sensitivity of responses to ATP. Both N-(2′-pyridyl)phthalide and 2,3′-nitrophenylisatogen was less neuroprotective than PIT (10 mg kg −1, i.p.) in protecting against the S-bromo-willardiine-induced lesions in mice, implying that both antagonism of P2Y receptors and the immine oxide moiety may be important for the neuroprotective effects of PIT. However, the usefulness of the neuroprotection was limited because, in motoneurones obtained from rat embryos, PIT (10–100 μM) exacerbated cell death.</description><subject>2,2′-Pyridylisatogen</subject><subject>AMPA receptor</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>ATP antagonist</subject><subject>Biological and medical sciences</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Guinea Pigs</subject><subject>Immine oxide</subject><subject>Isatin - analogs &amp; derivatives</subject><subject>Isatin - pharmacology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Motoneuron</subject><subject>Motor Neurons - drug effects</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle, Smooth - drug effects</subject><subject>Neuropharmacology</subject><subject>Neuroprotection</subject><subject>Neuroprotective agent</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>P2Y receptor</subject><subject>Pharmacology. Drug treatments</subject><subject>Purinergic P2 Receptor Antagonists</subject><subject>Spin trap</subject><subject>Spin Trapping</subject><subject>Structure-Activity Relationship</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc2KFDEUhYMoTjv6CEo2ioKluUlXpbISGfyDAcWfhauQSm61kapKmaQGeufW1_GRfBJT3Y2zdHUv4Ts3h3MIuQ_sGTBonn9iDLYVV0o9ZvwJg7oVFb9BNtBKVTEJ_CbZ_EPOyJ2UvjPGasXr2-QMOKii4Bvy62MYkIaeptlPNEczl7mjZnL0A_9KI1qcc4jlIZtdmHwa6cp9QzrhEsMcQ0ab_RVS7PuypfUWf8r__Pxdzfvo3X7wyeSww6IKaT-YjIfrEdfVURvGOSyTS3fJrd4MCe-d5jn58vrV54u31eX7N-8uXl5WVijIFYJTnQLsABUzttsCdK1C6RzUshe2lRaVkNxJANU2rmn6DlE4ZAbQWSHOyaPj3eL9x4Ip69Eni8NgJgxL0pIzLrcCClgfQRtDShF7PUc_mrjXwPTagT50oNeANeP60IHmRffg9MHSjeiuVafQC_DwBJhkzdBHM1mfrrniXohGFu7FkcMSx5XHqJP1OFl0vvSStQv-P1b-Akfzp1s</recordid><startdate>20020524</startdate><enddate>20020524</enddate><creator>Menton, Kevin</creator><creator>Spedding, Michael</creator><creator>Gressens, Pierre</creator><creator>Villa, Pascal</creator><creator>Williamson, Toni</creator><creator>Markham, Anthony</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020524</creationdate><title>Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2′-pyridylisatogen tosylate and related compounds</title><author>Menton, Kevin ; Spedding, Michael ; Gressens, Pierre ; Villa, Pascal ; Williamson, Toni ; Markham, Anthony</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-e1d9b91eb1e90acb411b89e7dd157f3c87ce9372d711986d66fbee3de0a1edc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>2,2′-Pyridylisatogen</topic><topic>AMPA receptor</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>ATP antagonist</topic><topic>Biological and medical sciences</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Guinea Pigs</topic><topic>Immine oxide</topic><topic>Isatin - analogs &amp; derivatives</topic><topic>Isatin - pharmacology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Motoneuron</topic><topic>Motor Neurons - drug effects</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle, Smooth - drug effects</topic><topic>Neuropharmacology</topic><topic>Neuroprotection</topic><topic>Neuroprotective agent</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>P2Y receptor</topic><topic>Pharmacology. Drug treatments</topic><topic>Purinergic P2 Receptor Antagonists</topic><topic>Spin trap</topic><topic>Spin Trapping</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Menton, Kevin</creatorcontrib><creatorcontrib>Spedding, Michael</creatorcontrib><creatorcontrib>Gressens, Pierre</creatorcontrib><creatorcontrib>Villa, Pascal</creatorcontrib><creatorcontrib>Williamson, Toni</creatorcontrib><creatorcontrib>Markham, Anthony</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Menton, Kevin</au><au>Spedding, Michael</au><au>Gressens, Pierre</au><au>Villa, Pascal</au><au>Williamson, Toni</au><au>Markham, Anthony</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2′-pyridylisatogen tosylate and related compounds</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2002-05-24</date><risdate>2002</risdate><volume>444</volume><issue>1</issue><spage>53</spage><epage>60</epage><pages>53-60</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>2,2′-Pyridylisatogen tosylate (PIT) is both an allosteric modulator of P2Y receptors, and an immine oxide, acting as a spin trap for free radicals. PIT (10 mg kg −1, i.p.) was found to be a powerful neuroprotective agent in protecting against the lesions induced by 15 μg S-bromo-willardiine injected into the cortex or white matter of 5-day-old mice pups. As the multiple effects of PIT may induce both beneficial and deleterious effects, a reanalysis of the structure–activity relationship was undertaken. PIT (50 μM) and 2,3′-pyridylisatogen were potent antagonists of responses to ATP in the taenia preparation of the guinea-pig caecum, but 2,3′-nitrophenylisatogen was not. The reactive immine oxide group could be substituted by a keto moiety ( N-(2′-pyridyl)phthalide) while maintaining antagonism of responses to ATP, equivalent to PIT. Thus, antagonism of P2Y receptors was not restricted to the isatogen nucleus. Other spin traps did not antagonise P2Y receptors, although dimethyl-pyrroline- N-oxide (DMPO) increased the sensitivity of responses to ATP. Both N-(2′-pyridyl)phthalide and 2,3′-nitrophenylisatogen was less neuroprotective than PIT (10 mg kg −1, i.p.) in protecting against the S-bromo-willardiine-induced lesions in mice, implying that both antagonism of P2Y receptors and the immine oxide moiety may be important for the neuroprotective effects of PIT. However, the usefulness of the neuroprotection was limited because, in motoneurones obtained from rat embryos, PIT (10–100 μM) exacerbated cell death.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>12191582</pmid><doi>10.1016/S0014-2999(02)01583-2</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 2002-05, Vol.444 (1), p.53-60
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_72027431
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects 2,2′-Pyridylisatogen
AMPA receptor
Animals
Animals, Newborn
ATP antagonist
Biological and medical sciences
Dose-Response Relationship, Drug
Female
Guinea Pigs
Immine oxide
Isatin - analogs & derivatives
Isatin - pharmacology
Medical sciences
Mice
Motoneuron
Motor Neurons - drug effects
Muscle Contraction - drug effects
Muscle, Smooth - drug effects
Neuropharmacology
Neuroprotection
Neuroprotective agent
Neuroprotective Agents - pharmacology
P2Y receptor
Pharmacology. Drug treatments
Purinergic P2 Receptor Antagonists
Spin trap
Spin Trapping
Structure-Activity Relationship
title Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2′-pyridylisatogen tosylate and related compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T06%3A11%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20spin%20trapping%20and%20P2Y%20receptor%20antagonism%20in%20the%20neuroprotective%20effects%20of%202,2%E2%80%B2-pyridylisatogen%20tosylate%20and%20related%20compounds&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Menton,%20Kevin&rft.date=2002-05-24&rft.volume=444&rft.issue=1&rft.spage=53&rft.epage=60&rft.pages=53-60&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/S0014-2999(02)01583-2&rft_dat=%3Cproquest_cross%3E72027431%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72027431&rft_id=info:pmid/12191582&rft_els_id=S0014299902015832&rfr_iscdi=true